Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells
Top Cited Papers
Open Access
- 28 March 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 29 (5), 1049-1056
- https://doi.org/10.1093/carcin/bgn078
Abstract
Novel dietary agents for prevention and therapy of prostate cancer (PCa) are desired. The aim of this study was to determine the effect of fisetin, a tetrahydroxyflavone, on inhibition of cell growth and induction of apoptosis in human PCa cells. Treatment of fisetin (10–60 μM, 48 h) was found to result in a decrease in the viability of LNCaP, CWR22Rυ1 and PC-3 cells but had only minimal effects on normal prostate epithelial cells as assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazoliumbromide assay. Treatment of LNCaP cells with fisetin also resulted in G 1 -phase arrest that was associated with a marked decrease in the protein expression of cyclins D1, D2 and E and their activating partner cyclin-dependent kinases 2, 4 and 6 with concomitant induction of WAF1/p21 and KIP1/p27. Fisetin treatment also resulted in induction of apoptosis, poly (ADP-ribose) polymerase (PARP) cleavage, modulation in the expressions of Bcl-2 family proteins, inhibition of phosphatidyl inositol 3-kinase and phosphorylation of Akt at Ser 473 and Thr 308 . There was also induction of mitochondrial release of cytochrome c into cytosol, downregulation of X-linked inhibitor of apoptosis protein and upregulation of second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI on treatment of cells with fisetin. Treatment of cells with fisetin also resulted in significant activation of caspases-3, -8 and -9. Pretreatment of cells with caspase inhibitor (Z-VAD-FMK) blocked fisetin-induced activation of caspases. These data provide the first evidence that fisetin could be developed as an agent against PCa.Keywords
This publication has 33 references indexed in Scilit:
- Phosphoprotein levels, MAPK activities and NFκB expression are affected by fisetinJournal of Enzyme Inhibition and Medicinal Chemistry, 2008
- Dulxanthone A induces cell cycle arrest and apoptosis via up‐regulation of p53 through mitochondrial pathway in HepG2 cellsInternational Journal of Cancer, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle ArrestPublished by Elsevier BV ,2006
- Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memoryProceedings of the National Academy of Sciences of the United States of America, 2006
- Polyphenols from green tea and pomegranate for prevention of prostate cancerFree Radical Research, 2006
- The role of nutrition in cancer development and preventionInternational Journal of Cancer, 2004
- Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002
- The Hallmarks of CancerCell, 2000